- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.10. | Modular Medical launches digital tools for insulin pump training | 2 | Investing.com | ||
| 15.10. | Modular Medical, Inc.: Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery System | 252 | ACCESS Newswire | Game-Based Education Tools Designed to Help Improve Patient Familiarity with Pump Therapy and Support Healthcare Providers in Identifying Candidates for Pump Adoption SAN DIEGO, CA / ACCESS Newswire... ► Artikel lesen | |
| 07.10. | Modular Medical, Inc.: Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th | 278 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / October 7, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 29.09. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.09. | Modular Medical, Inc.: Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026 | 345 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 04.09. | Modular Medical Aktie steigt nach Vertrag mit führendem Pharmacy Benefit Manager | 2 | Investing.com Deutsch | ||
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 04.09. | Modular Medical sichert sich Vertrag mit landesweitem US-Apothekenmanager | 1 | Investing.com Deutsch | ||
| 04.09. | Modular Medical secures contract with national U.S. pharmacy manager | 2 | Investing.com | ||
| 04.09. | Modular Medical, Inc.: Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump | 460 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial... ► Artikel lesen | |
| 03.09. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.09. | Modular Medical, Inc.: Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements | 396 | ACCESS Newswire | Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot Customization SAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / Modular Medical, Inc. ("Modular Medical" or "the... ► Artikel lesen | |
| 03.09. | EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades | 2 | Benzinga.com | ||
| 02.09. | Modular Medical, Inc.: Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled 'The Road To Revenue: Modular Medical's Strategy For Launching Pivot' Featuring Modular Medical CEO - Friday, September 4, 2026 | 464 | ACCESS Newswire | Meet with Modular Medical CEO Jeb Besser.Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal... ► Artikel lesen | |
| 02.09. | 6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More | 941 | AFX News | BEIJING (dpa-AFX) - Today's after-hours gainers in the healthcare sector included Universe Pharmaceuticals, which drew attention after disclosing multiple Schedule 13G filings; bioAffinity Technologies... ► Artikel lesen | |
| 14.08. | Modular Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.08. | Modular Medical, Inc.: Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference | 429 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 04.08. | Modular Medical to initiate first phase of Pivot pump launch in October | 1 | MassDevice | ||
| 03.08. | Modular Medical, Inc.: Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026 | 511 | ACCESS Newswire | First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption... ► Artikel lesen | |
| 23.07. | Modular Medical forms advisory council for Pivot insulin pump | 3 | Investing.com | ||
| 23.07. | Modular Medical, Inc.: Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman | 353 | ACCESS Newswire | - Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular... ► Artikel lesen |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,692 | +1,57 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,072 | -2,69 % | SONDERMELDUNG: Warum die Aktie von Sernova Biotherapeutics von unseren Experten eine 3+ bekommt - Mein Rat: sofort handeln! | ||
| CERENOME | 1,412 | +1,15 % | Cerenome, Inc.: Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ' | ||
| ATOSSA THERAPEUTICS | 2,280 | +0,88 % | Atossa Therapeutics: Stammaktien handeln ab sofort gekoppelt mit Contingent Value Rights | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 15,100 | 0,00 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,630 | -1,92 % | Joint Venture von Co-Diagnostics zu saudi-arabischem Fertigungsforum eingeladen | ||
| QUIDELORTHO | 12,585 | +0,36 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,270 | -1,30 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 5,490 | 0,00 % | 6,4 Millionen US-Dollar pro Patient: Warum Medtronic, Lifeward und NurExone an drei Stufen der Rückenmarksversorgung ansetzen | ||
| CLOVER HEALTH INVESTMENTS | 4,220 | -0,71 % | Clover Health Investments, Corp.: Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States | ||
| SENSEONICS | 7,250 | +2,11 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| NANO-X IMAGING | 0,392 | +1,84 % | Nanox meldet vorläufigen Q3-Umsatz von bis zu $4,4 Millionen | ||
| TEMPEST THERAPEUTICS | 0,540 | +3,17 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| IMUNON | 1,040 | 0,00 % | IMUNON veräußert ThermoDox-Rechte an VoxelDox Therapeutics |
Das Unternehmen MODULAR MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,100 (-5,08 %) liegt der Kurs bei 1,870 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MODULAR MEDICAL INC finden Sie auf Wallstreet Online.